Stimulation with a commercial T cell activation kit led to increased granzyme B expression in tumor cells, heightened granzyme B release into culture supernatants (Figure 4), and upregulated pro-apoptotic cleaved caspase 3 in tumor cells under control conditions (Figure 3), aligning with previous publications (22). The gene discussed is GZMB; the disease is neoplasm.